Laura Villarreal‐Martínez

Phase 3 Trial of Concizumab in Hemophilia with Inhibitors

Tadashi Matsushita, Amy D. Shapiro, Aby Abraham et al. · New England Journal of Medicine · 2023 · 114 citations · Full text

Medicine, Hematology, Pharmacotherapy +13

The effect of intra‐articular injection of autologous bone marrow stem cells on pain and knee function in patients with osteoarthritis

Domingo Garay‐Mendoza, Laura Villarreal‐Martínez, Alejandra Garza‐Bedolla et al. · International Journal of Rheumatic Diseases · 2017 · 91 citations · Full text

Medicine, Orthopaedic Surgery, Orthopedic Surgery +17

Safety and tolerability of intrathecal delivery of autologous bone marrow nucleated cells in children with cerebral palsy: an open-label phase I trial

Consuelo Mancías‐Guerra, Alma Rosa Marroquín-Escamilla, Óscar González‐Llano et al. · Cytotherapy · 2014 · 58 citations

Medicine, Neurology, Cell Therapy +13

Concizumab prophylaxis in people with haemophilia A or haemophilia B without inhibitors (explorer8): a prospective, multicentre, open-label, randomised, phase 3a trial

Pratima Chowdary, Pantep Angchaisuksiri, Shashikant Apte et al. · The Lancet Haematology · 2024 · 34 citations · Full text

Medicine, Hematology, Pharmacology +3

More about low-dose rituximab and plasma exchange as front-line therapy for patients with thrombotic thrombocytopenic purpura

Alberto Vázquez-Mellado, Myrna Pequeño-Luévano, Olga Graciela Cantú‐Rodríguez et al. · Hematology · 2016 · 25 citations · Full text

Medicine, Hematology, Immunology +11